HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical characteristics and outcomes of primary antibody deficiency: a 20-year follow-up study.

AbstractBACKGROUND/PURPOSE:
Primary antibody deficiency is the most common disorder among primary immunodeficiencies. Recurrent infection and chronic lung change often lead to mortality and morbidity.
METHODS:
This study focused on the clinical presentation, molecular diagnosis, and outcomes of primary antibody deficiency in Taiwan pediatric group. Medical records of patients with primary antibody deficiency during the period 1990-2010 were retrospectively reviewed in one medical center.
RESULTS:
Among the 34 patients evaluated, X-linked agammaglobulinemia (XLA) (29.4%) and common variable immunodeficiency diseases (CVIDs) (29.4%) were the most common disorders presented with respiratory and skin infections. Some genotype/phenotype discordance was found in one family. Patients with XLA, CVID, and hyper-IgM syndrome without complications had higher trough and initial IgG levels, and shorter delays in diagnosis. Patients with trough IgG levels >700 mg/dL had less occurrence of bronchiectasis.
CONCLUSION:
These results summarized clinical manifestations of primary antibody deficiency in pediatric group in Taiwan. Clinicians should strive to shorten delays in diagnosis and maintain higher trough IgG levels to decrease subsequent mortality and morbidity.
AuthorsHung-Yi Chan, Yao-Hsu Yang, Hsin-Hui Yu, Yin-Hsiu Chien, Li-Lan Chiang, Bor-Luen Chiang
JournalJournal of the Formosan Medical Association = Taiwan yi zhi (J Formos Med Assoc) Vol. 113 Issue 6 Pg. 340-8 (Jun 2014) ISSN: 0929-6646 [Print] Singapore
PMID24820629 (Publication Type: Journal Article)
CopyrightCopyright © 2012. Published by Elsevier B.V.
Topics
  • Adolescent
  • Child
  • Female
  • Follow-Up Studies
  • Humans
  • Immunologic Deficiency Syndromes (diagnosis, genetics, therapy)
  • Infant
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: